))
Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients
Manage episode 467672149 series 2786623
Content provided by American Association of Hip and Knee Surgeons, American Association of Hip, and Knee Surgeons. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Association of Hip and Knee Surgeons, American Association of Hip, and Knee Surgeons or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
At the 2024 AAHKS Annual Meeting, our Digital Health Committee Chair Shaun P. Patel, MD and Committee Member William B. Kurtz, MD had the pleasure of speaking with Saad Tarabichi, MD about his study presented at the meeting on “Glycated Albumin as a Predictor of Outcomes in Primary TJA Patients.”
In this really study on a very common issue in the US – diabetes, Dr. Tarabichi uncovered that detecting diabetes is not as simple as we think it is. A study that initially starting with a FARE Grant by AAHKS recieved two years ago began looking into glycated albumin, a very standardized test. The study later consisted of a study with 1200 enrolled patients and Dr. Tarabichi predicting 90-day outcomes from these enrolled patients. Take a listen, I think the findings in this study will really surprise you.
Enjoy, and thanks for listening to AAHKS Amplified!
In This Episode:
William B. Kurtz, MD
Shaun P. Patel, MD
Saad Tarabichi, MD
82 episodes
Share
